Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: A vaccine safety datalink study

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages 165-

  Jackson, Lisa A ^a   Yu, Onchee ^a   Belongia, Edward A ^b   Hambidge, Simon J ^c   Nelson, Jennifer ^a,d   Baxter, Roger ^e   Naleway, Allison ^e   Gay, Charlene ^f   Nordin, James ^g   Baggs, James ^h   Iskander, John ^h  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b MARSHFIELD CLINIC   (United States)

^c DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e KAISER PERMANENTE   (United States)

^f HARVARD PILGRIM HEALTH CARE   (United States)

^g HEALTHPARTNERS INSTITUTE   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DIPHTHERIA TETANUS TOXOID; DIPHTHERIA VACCINE; MENINGOCOCCUS VACCINE; TETANUS TOXOID;

ADOLESCENT; ADULT; ARTICLE; CELLULITIS; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRUG SAFETY; FEVER; HUMAN; INCIDENCE; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SKIN ULCER; VACCINATION;

EID: 70449481597     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-165     Document Type: Article

References (19)

1. Wassilak SGF, Roper MR, Kretsinger K, Orenstein WA. Tetanus toxoid. Vaccines 2008, 805-840. Philadelphia: Elsevier Inc, Plotkin SA, Orenstein WA, Offit PA, 5 .
2. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 1997, 99(6):765-773. 10.1542/peds.99.6.765, 9164767.
3. DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf 2001, 10(5):403-406. 10.1002/pds.613, 11802585.
4. Ruggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, de Souza Brito G, Heininger U, Imoukhuede B, Khamesipour A. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25(31):5675-5684. 10.1016/j.vaccine.2007.02.064, 17448577.
5. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991, 10(4):585-598. 10.1002/sim.4780100410, 2057657.
6. Scheifele DW, Dobson S, Kallos A, Bjornson G, Ochnio JJ. Comparative safety of tetanus-diphtheria toxoids booster immunization in students in Grades 6 and 9. Pediatr Infect Dis J 1998, 17(12):1121-1126. 10.1097/00006454-199812000-00004, 9877359.
7. Recommended childhood immunization schedule--United States, 1995. Centers for Disease Control and Prevention. MMWR Recomm Rep 1995, 44(RR-5):1-9.
8. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Recomm Rep 1996, 45(RR-13):1-16.
9. Halperin SA, Sweet L, Baxendale D, Neatby A, Rykers P, Smith B, Zelman M, Maus D, Lavigne P, Decker MD. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?. Pediatr Infect Dis J 2006, 25(3):195-200. 10.1097/01.inf.0000202082.56403.c4, 16511379.
10. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006, 55(RR-17):1-37.
11. Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-3):1-34.
12. Jackson LA, Carste BA, Malais D, Froeschle J. Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. Pediatr Infect Dis J 2002, 21(8):781-786. 10.1097/00006454-200208000-00016, 12192169.
13. Rennels MB, Deloria MA, Pichichero ME, Losonsky GA, Englund JA, Meade BD, Anderson EL, Steinhoff MC, Edwards KM. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 2000, 105(1):e12. 10.1542/peds.105.1.e12, 10617749.
14. Rennels MB, Black S, Woo EJ, Campbell S, Edwards KM. Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose. Pediatr Infect Dis J 2008, 27(5):464-465. 10.1097/INF.0b013e31816591f7, 18398385.
15. Sekaran NK, Edwards KM. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine. Pediatr Infect Dis J 2006, 25(4):374-375. 10.1097/01.inf.0000207431.91375.5f, 16567996.
16. Scheifele DW, Halperin SA, Ferguson AC. Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens. Vaccine 2001, 19(32):4720-4726. 10.1016/S0264-410X(01)00230-4, 11535322.
17. Liese JG, Stojanov S, Zink TH, Froeschle J, Klepadlo R, Kronwitter A, Harzer E, Jow S, Belohradsky BH. Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study Group. Pediatr Infect Dis J 2001, 20(10):981-988. 10.1097/00006454-200110000-00012, 11642633.
18. Woo EJ, Burwen DR, Gatumu SN, Ball R. Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. Clin Infect Dis 2003, 37(3):351-358. 10.1086/375820, 12884159.
19. Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB, Mullooly JP, Thompson RS. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003, 112(4):815-820. 10.1542/peds.112.4.815, 14523172.